8-KFinancial EventsExhibits & Filings

DEXCOM INC 8-K Report, Auditor Change (Mar 25, 2025)

Filed March 25, 2025For Securities:DXCM

Summary

DexCom, Inc. (DXCM) has announced a change in its independent registered public accounting firm. The Audit Committee of the Board of Directors, on March 21, 2025, dismissed Ernst & Young LLP (EY) as the Company's auditor. This change is effective for the fiscal years ended December 31, 2024 and 2023, and the subsequent interim period. The company states that there were no disagreements or reportable events with EY during these periods, and EY has confirmed its agreement with this statement. This transition is a routine procedural event, but investors should be aware of the change in auditor. Concurrently, DexCom has engaged Deloitte & Touche LLP (Deloitte) as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. The company has confirmed that there were no consultations with Deloitte on accounting principles, disagreements, or reportable events prior to this engagement. The engagement of a new auditor is a common occurrence and typically does not indicate any underlying issues with the company's financial reporting, but it does mark a significant change in the oversight of DexCom's financial statements.

Key Highlights

  • 1DexCom, Inc. (DXCM) has dismissed Ernst & Young LLP (EY) as its independent registered public accounting firm.
  • 2The dismissal was effective as of March 21, 2025.
  • 3The company stated there were no disagreements or reportable events with EY during the relevant periods.
  • 4EY has provided a letter confirming its agreement with DexCom's statements regarding the dismissal.
  • 5DexCom has appointed Deloitte & Touche LLP (Deloitte) as its new independent registered public accounting firm.
  • 6Deloitte has been engaged for the fiscal year ending December 31, 2025.
  • 7There were no prior consultations with Deloitte on accounting matters that were considered important to DexCom's decisions.

Frequently Asked Questions

The Form 8-K filing indicates that the dismissal was a decision made by the Audit Committee of the Board of Directors. The company has stated that there were no disagreements or reportable events with EY during the recent fiscal years and subsequent interim period, suggesting this was not due to accounting disputes or audit concerns.

Typically, a change in auditor is a routine corporate governance matter and not necessarily an indicator of financial distress. The company's statements and EY's agreement suggest the transition was amicable and without contention. However, investors should monitor the upcoming financial reports audited by the new firm.

Deloitte is one of the 'Big Four' accounting firms, known for its extensive experience in auditing public companies. Their appointment signifies DexCom's commitment to maintaining robust financial oversight with a new, highly reputable audit partner for the upcoming fiscal year.

This statement indicates that DexCom did not seek advice from Deloitte on significant accounting or auditing matters before engaging them as their auditor for the fiscal year ending December 31, 2025. This is common when appointing a new auditor and does not suggest any issues.